Skip to content
HowShorted

Aimmune Therapeutics, Inc. short interest in 2020

In 2020, Aimmune Therapeutics, Inc.'s disclosed short interest ran from 18.27% of shares outstanding on 15 Jan 2020 to 27.28% on 31 Aug 2020, a change of +9.01 percentage points. The year's high was 29.06% on 30 Jun 2020 and its low 18.27% on 15 Jan 2020, averaging 25.33% across 16 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 24.29 days on 29 May 2020. Full history: Aimmune Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020

Aggregate net short position time series for Aimmune Therapeutics, Inc. in 2020

2020 in figures

Start of year
18.27% (15 Jan 2020)
End of year
27.28% (31 Aug 2020)
Change
+9.01 pp
High
29.06% (30 Jun 2020)
Low
18.27% (15 Jan 2020)
Average
25.33%
Highest days to cover
24.29 (29 May 2020)
SEC filings marked
6

Every report in 2020

Aimmune Therapeutics, Inc. short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 202018.27%10.39
31 Jan 202018.94%12.47
14 Feb 202022.45%4.68
28 Feb 202023.30%9.8410-K filed, results (8-K)
13 Mar 202021.85%10.97
31 Mar 202023.79%6.96
15 Apr 202025.44%14.13
30 Apr 202027.01%16.71
15 May 202027.90%16.8310-Q filed, results (8-K)
29 May 202027.46%24.29
15 Jun 202027.64%17.88
30 Jun 202029.06%13.18
15 Jul 202028.06%19.42
31 Jul 202028.68%22.8210-Q filed, results (8-K)
14 Aug 202028.14%21.05
31 Aug 202027.28%19.98

See also: Aimmune Therapeutics, Inc.'s full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.